Medeon Biodesign (ROCO:6499) COGS-to-Revenue : 0.91 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Medeon Biodesign COGS-to-Revenue?

Medeon Biodesign's Cost of Goods Sold for the three months ended in Mar. 2024 was NT$43.0 Mil. Its Revenue for the three months ended in Mar. 2024 was NT$47.1 Mil.

Medeon Biodesign's COGS to Revenue for the three months ended in Mar. 2024 was 0.91.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Medeon Biodesign's Gross Margin % for the three months ended in Mar. 2024 was 8.81%.

Medeon Biodesign COGS-to-Revenue Historical Data

The historical data trend for Medeon Biodesign's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeon Biodesign COGS-to-Revenue Chart

Medeon Biodesign Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.29

0.59

0.62

0.58

0.37

Medeon Biodesign Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.80	0.85	0.92	1.00	0.91

Medeon Biodesign COGS-to-Revenue Calculation

Medeon Biodesign's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	111.505	/	298.317
	=	0.37

Medeon Biodesign's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	42.987	/	47.141
	=	0.91

Medeon Biodesign (ROCO:6499) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Medeon Biodesign's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	42.987 / 47.141
	=	8.81 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Medeon Biodesign COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medeon Biodesign's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medeon Biodesign (ROCO:6499) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medeon Biodesign Inc (ROCO:6499) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170

Website

http://www.medeonbio.com

Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.

Medeon Biodesign (ROCO:6499) Headlines

No Headlines